MedElevator Войти в исследования
← Поиск публикаций

DOI 10.26574/maedica.2026.21.3.749

Медицинская библиотека · Maedica · 2026

Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma and Combination Strategies.

Pantelis P, Damaskos C, Garmpis N, Tsourouflis G, Dimitroulis D

СтатьяОбзорПеревод пока не подготовлен

Аннотация

OBJECTIVES

This review provides a comprehensive overview of transarterial radioembolization (TARE) using Yttrium-90 (Y-90), a minimally invasive locoregional therapy for HCC patients who are ineligible for surgical resection.

MATERIAL AND

METHODS

A narrative review of the literature was conducted using PubMed/MEDLINE and Scopus databases. Studies focusing on patient selection, technical aspects, dosimetry, safety, oncologic outcomes and combination strategies were included. Clinical guidelines, prospective and retrospective studies, and comparative analyses were synthesized. A total of 43 key publications were synthesized, including landmark randomized controlled trials (SARAH, SIRveNIB, DOSISPHERE-01), recent meta-analyses and current clinical practice guidelines from EASL, AASLD and ESMO.

RESULTS

Transarterial radioembolization demonstrates high objective response rates and favorable survival outcomes across Barcelona Clinic Liver Cancer (BCLC) stages, with a favorable safety profile compared to systemic therapies. Personalized dosimetry approaches significantly improve response rates as demonstrated in the DOSISPHERE-01 trial. Combination strategies with immune checkpoint inhibitors and tyrosine kinase inhibitors show promising synergistic potential, supported by ongoing phase II/III trials including IMMUWIN, ROWAN and EMERALD-Y90.

CONCLUSIONS

Transarterial radioembolization is a safe and effective locoregional therapy for HCC, with expanding indications including radiation segmentectomy with curative intent, downstaging for transplantation and combination with systemic therapies. Future research should focus on optimal sequencing, personalized dosimetry thresholds and identification of patients who are most likely to benefit from combination approaches.

Для цитирования: Pantelis P, Damaskos C, Garmpis N, Tsourouflis G, Dimitroulis D. Transarterial Radioembolization in the Treatment of Hepatocellular Carcinoma and Combination Strategies.. Maedica. 2026. DOI: 10.26574/maedica.2026.21.3.749.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.